# CNCR (Range Cancer Therapeutics ETF)

not established · Thematic ETFs · data as of Sep 11, 2026

Not updated since Sep 11, 2026. Its price did not move on 29 of its last 29 closes. These are its last figures. It is not in ETFIQ’s rankings, scores or comparisons while they are out of date.

CNCR: ETFIQ holds no book of its holdings, so there is nothing to look through.

## Key facts

- CNCR, total return, since launch: 0.0%, as of Sep 11, 2026.

## CNCR over each window to Sep 11, 2026

| Window | Total return | S&P 500 (SPY) | Gap to SPY | Gap to QQQ |
| --- | --- | --- | --- | --- |
| 3 months | 0.0% | +3.3% | −3.3 pts | +0.8 pts |
| 6 months | 0.0% | +15.4% | −15.4 pts | −20.0 pts |
| Since launch | 0.0% | +11.3% | −11.3 pts | −17.5 pts |

## Every published field

| Field | Value | Source |
| --- | --- | --- |
| Theme | Therapeutics and medical devices | ETFIQ, editorial |
| First traded | Feb 6, 2026 | ETFIQ |
| Below its all-time high | 0.0% | ETFIQ |

## Questions

### Has CNCR beaten the S&P 500?

Over the year to Sep 11, 2026 CNCR returned 0.0% with distributions reinvested, against +11.3% for the S&P 500, so it finished behind the index by 11.3 points.


## Cite this page

ETFIQ, CNCR, thematic ETFs, data as of Sep 11, 2026. https://etfiq.com/funds/cncr
Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at https://etfiq.com/data/.

HTML: https://etfiq.com/funds/cncr  ·  JSON: https://etfiq.com/funds/cncr.json